COMBINATION OF GLICLAZIDE DRUG AND LUPIN SEEDS POWDER ALLEVIATE HYPERGLYCEMIA ON INDUCED-DIABETIC RATS RECEIVING HIGH-FAT HIGH FRUCTOSE/SUCROSE DIET

Samah S. Khalil, Haytham A. Ali, Hamad A. Al-Saadawy, Khalifa E. Ahmad

Abstract


Diabetes mellitus is one of the most prevalent metabolic diseases in the world. Hyperglycemia and lipoprotein abnormalities are the characteristic clinical finding of DM. The most common legume food used in traditional medicine for the treatment of diabetes is lupin seeds powder. The aim of current research is to analyze the therapeutic effects of the combination of both hypoglycemic drug (Gliclazide) and  lupin seeds powder on some biochemical parameters (serum blood  glucose, serum insulin, glyclated hemoglobin and total lipid profile) and also on mRNA expression level of Glucokinase, Phosphoenolpyruvate carboxykinase (PEPCK), Insulin and Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-γ) genes using relative quantitative PCR.  In this study, thirty zucker male rats were divided into two groups: normal control group (six rats) and the other group expose to induce type2 DM by high-fat high fructose/sucrose diet.  The diabetic groups were sub classified  into 4groups (6 rats in each group), one group diabetic control and the rest was treated with Gliclazide (10mg/kg),combination of Gliclazide(10mg/kg) and lupin seeds powder (1gm/kg) and lupin seeds powder (1gm/kg) only. Combination between Gliclazide (10mg/kg) and lupin seeds powder (1gm/kg) daily for 4 weeks resulted in significant decrease in blood glucose level, glyclated hemoglobin and dyslipidemia (p<0.05), also results in significant increase (P<0.05) in high density lipoprotein-cholesterol(HDL-c) (90.66±3.8), insulin level(4.9±0.058). Also the combination of Gliclazide (10mg/kg) and lupin seeds powder (1gm/kg) tends to return biochemical parameters, lipid profile (triacylglycerol 77±3.05, total cholesterol 132±2) and the transcription of mRNA metabolic genes to normal levels ( Glucokinase 1.4±0.1, insulin 1.48±0.25, PEPCK 0.49±0.25, PPAR-γ 3.1±0.2 ) more than the treatment with Gliclazide drug only, in type 2 diabetic rats. It is concluded that, the combination of Gliclazide hypoglycemic drug and lupin seeds powder has the most hypoglycemic effect when compared to other groups.

Key words: type2 diabetes mellitus; high-fat high fructose/sucrose diet; gliclazide; lupin seeds; total cholesterol


Full Text:

PDF

References


(1) Marcil V, Amre D, Seidman EG, Boudreau F, Gendron FP, Ménard D, Beaulieu JF, Sinnett D, Lambert M, Levy E. Hepatocyte nuclear factor 4 alpha polymorphisms and the metabolic syndrome in French-Canadian youth. PloS one 2015; 10e0117238.

(2) Röder PV, Wu B, Liu Y, Han W. Pancreatic regulation of glucose homeostasis. Exp Mol Med 2016; 48e219.

(3) Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev 2013; 9: 25–53.

(4) Siddiqui AA, Siddiqui SA, Ahmad S, Siddiqui S, Ahsan I, Sahu K. Diabetes: Mechanism, Pathophysiology and Management-A Review. Int J Drug Dev Res. · 2013; 5: 1–23.

(5) Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J ethnopharmacol 2004; 92: 1–21.

(6) Malviya N, Jain S, Malviya SA. Antidiabetic potential of medicinal plants. Acta Pol Pharm 2010; 67: 113-8.

(7) Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2012;2: 320

(8) Villarino CB, Jayasena V, Coorey R, Chakrabarti-Bell S, Foley R, Fanning K, Johnson SK. The effects of lupin (Lupinus angustifolius) addition to wheat bread on its nutritional, phytochemical and bioactive composition and protein quality. Food Research International. 2015;76: 58–65.

(9) Simpson SH, Lee J, Choi S, Vandermeer B, Abdelmoneim AS, Featherstone TR. Mortality risk among sulfonylureas: a systematic review and network meta-analysis. Lancet Diabetes Endocrinol 2015;3: 43–51

(10) Hung HY, Qian K, Morris-Natschke SL, Hsu CS, Lee KH. Recent discovery of plant-derived anti-diabetic natural products. Nat Prod Rep 2012; 29: 580-606.

(11) Terruzzi I, Senesi P, Magni C, Montesano A, Scarafoni A, Luzi L, et al. Insulin-mimetic action of conglutin-γ, a lupin seed protein, in mouse myoblasts. Nutrition, Metabolism and Cardiovascular Diseases. 2011;21: 197–205.

(12) de Castro UG, Silva ME, de Lima WG, Campagnole-Santos MJ, Alzamora AC. Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. Lipids Health Dis 2013; 12: 136.

(13) Gancheva S, Zhelyazkova-Savova M, Galunska B, Chervenkov T. Experimental models of metabolic syndrome in rats. Scripta Scientifica Medica 2015; 47: 14–21.

(14) El-Sayed SM. Lupine alleviate hypergly-cemia in streptozotcin diabetic γ-irradiated rats. J Rad Res Appl Sci. 2010; 3: 293–309.

(15) Eidi A, Eidi M, Sokhteh M. Effect of fenugreek (Trigonella foenum-graecum L) seeds on serum parameters in normal and streptozotocin-induced diabetic rats. Nutr Res 2007; 27: 728–33.

(16) El-Gayar KE, Ibrahim MA, Mohamed SH, Zakaria Z, Alhameed ASA. Application of extracted peroxidase enzyme from turnip roots (BRASSICA NAPUS) in clinical diagnostic kit. Int J Cur Res Rev 2012; 4; 17–22.

(17) Wang D, Zhu W, Li J, An C, Wang Z. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history. PloS one 2013; 8: e81190.

(18) Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. New England Journal of Medicine. 1971; 284: 353–7.

(19) Young DS. Effects of diseases on clinical lab. Tests. American Association for Clinical Chemistry. Inc, Washington DC. 2001.

(20) Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

(21) Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, Arima H, Monaghan H, Joshi R, Colagiuri S, Cooper ME. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. New England Journal of Medicine 2014; 371: 1392–406.

(22) Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476–82.

(23) Penttilä IM, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest. 1981; 41: 353–60.

(24) Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology. 2002 Jun; research 0034–1.

(25) Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 2001; 25: 402–8.

(26) Meng YK, Li CY, Li RY, He LZ, Cui HR, Yin P, Zhang CE, Li PY, Sang XX, Wang Y, Niu M. Cis-stilbene glucoside in Polygonum multiflorum induces immunological idiosyncratic hepatotoxicity in LPS-treated rats by suppressing PPAR-γ. Acta Pharmacol Sin 2017; 38: 1340.

(27) Ali HA, Almaghrabi OA, Afifi ME. Molecular mechanisms of anti-hyperglycemic effects of Costus speciosus extract in streptozotocin-induced diabetic rats. Saudi Med J 2014; 35: 1501.

(28) Li YG, Ji DF, Zhong S, Lin TB, Lv ZQ, Hu GY, Wang X.1-deoxynojirimycin inhibits glucose absorption and accelerates glucose metabolism in streptozotocin-induced diabetic mice. Sci Rep 2013; 3: 1377.

(29) Assaei R, Mokarram P, Dastghaib S, Darbandi S, Darbandi M, Zal F, Akmali M, Omrani GH Hypoglycemic effect of aquatic extract of stevia in pancreas of diabetic rats: PPARγ-dependent regulation or antioxidant potential. Avicenna J Med Biotechnol 2016; 8: 65.

(30) Schmittgen TD, Zakrajsek BA. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods 2000; 46: 69-81.

(31) Lozano I, Van der Werf R, Bietiger W, Seyfritz E, Peronet C, Pinget M, Jeandidier N, Maillard E, Marchioni E, Sigrist S, Dal S. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab. 2016; 13: 15.

(32) Pyörälä K, Ballantyne CM, Gumbiner B, Lee MW, Shah A, Davies MJ, Mitchel YB, Pedersen TR, Kjekshus J. Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S) . Diabetes Care 2004; 27: 1735–40.

(33) Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P, QUARTET Study Group. A long‐term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double‐blind, parallel‐group comparison trial. Diabetic Med 2005; 22: 399–405.

(34) Akram M, Hamid A. Mini review on fructose metabolism. Obes Res Clin Pract 2013; 7: e89-e94.

(35) Zoungas S, Patel A, Chalmers J, De Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE. Severe hypoglycemia and risks of vascular events and death. New England Journal of Medicine. 2010; 363: 1410–8.

(36) Weitgasser R, Lechleitner M, Luger A, Klingler A. Effects of glimepiride on HbA1c and body weight in Type 2 diabetes: results of a 1.5-year follow-up study. Diabetes Res Clin Pract 2003; 61: 13–19.

(37) Hassanein M, Abdallah K, Schweizer A. A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study. Vasc Health Risk Manag. 2014; 10: 319.

(38) Mahfoz AM, El-Latif HAA, Ahmed LA, Hassanein NM, Shoka AA. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats. Naunyn Schmiedebergs Arch Pharmacol. 2016; 389: 1315–24.

(39) Harrower A. Gliclazide modified release: From once-daily administration to 24-hour blood glucose control. Metab Clin Exp 2000; 49: 7–11.

(40) González-Santiago AE, Vargas-Guerrero B, García-López PM, Martínez-Ayala AL, Domínguez-Rosales JA, Gurrola-Díaz CM. Lupin-

us albus conglutin gamma modifies the gene expressions of enzymes involved in glucose hepatic production in vivo. Plant Foods Hum Nutr 2017; 72: 134–40.

(41) Marchesi M, Parolini C, Diani E, Rigamonti E, Cornelli L, Arnoldi A, Sirtori CR, Chiesa G.. Hypolipidaemic and anti-atherosclerotic effects of lupin proteins in a rabbit model. Br J Nutr 2008; 100: 707–10.

(42) Lovati MR, Manzoni C, Castiglioni S, Parolari A, Magni C, Duranti M. Lupin seed γ-conglutin lowers blood glucose in hyperglycaemic rats and increases glucose consumption of HepG2 cells. British Journal of Nutrition 2012; 107: 67-73.

(43) Lucas MM, Stoddard FL, Annicchiarico P, Frias J, Martinez-Villaluenga C, Sussmann D, Duranti M, Seger A, Zander PM, Pueyo JJ. The future of lupin as a protein crop in Europe. Front Plant Sci. 2015; 6: 705.

(44) Dove ER, Mori TA, Chew GT, Barden AE, Woodman RJ, Puddey IB, Sipsas S, Hodgson JM. Lupin and soya reduce glycaemia acutely in type 2 diabetes. Br J Nutr. 2011; 106: 1045–51.




DOI: http://dx.doi.org/10.26873/SVR-654-2018

Refbacks

  • There are currently no refbacks.